The aim. Development and validation of a high-performance liquid chromatography (HPLC) method for the determination of related substances in a combined syrup containing ibuprofen (20 mg/mL) and caffeine (40 mg/mL), considering the results of stress degradation studies. Materials and methods. Chromatography was performed on an Agilent 1260 liquid chromatograph equipped with a diode-array detector using a Waters Symmetry C8 column (250 × 4.6 mm, 5 µm) in gradient elution mode at 25 °C and a flow rate of 1.0 mL/min. An aqueous solution of potassium dihydrogen phosphate (6.8 g/L) and sodium hexanesulphonate (0.4 g/L) (pH adjusted to 3.0 with phosphoric acid) was used as mobile phase A. Acetonitrile was used as mobile phase B. Detection was carried out at a wavelength of 210 nm. The injection volume was 15 µL. Stress degradation studies were conducted under the influence of elevated temperature (80 °C), light exposure, a 10% hydrogen peroxide solution (oxidation), as well as acid and alkaline hydrolysis. Validation of the method for determining related substances was performed in terms of specificity, linearity, accuracy, precision, and robustness, alongside the evaluation of the limit of detection and limit of quantitation in accordance with the requirements of the State Pharmacopoeia of Ukraine and ICH Q2(R2) guidelines. Results. Optimal chromatographic conditions were selected and substantiated during the development of an HPLC method for the determination of related substances, ensuring selective separation of ibuprofen, caffeine, excipients, and related substances (caffeine impurities A and F, ibuprofen impurity B). Stress degradation studies revealed that ibuprofen and caffeine in the syrup formulation are stable to light exposure and acid hydrolysis. Elevated temperature has the most significant degradation effect (resulting in the formation of ibuprofen impurity B and an unidentified caffeine impurity with a relative retention time of 1.05), whilst oxidation causes partial degradation of both active pharmaceutical ingredients (APIs). Alkaline hydrolysis leads to caffeine degradation, resulting in the formation of three unidentified products (relative retention times: 0.95, 1.03 and 1.05). The developed method is linear in the range of 0.025-1.0% (R2>0,999), accurate (mean recovery is 100.15 % for ibuprofen and 101.28% for caffeine), precise (relative standard deviation, %RSD, did not exceed 2.87%), specific, and robust. The LOQ for caffeine is 0.002%, and for ibuprofen 0.040%; the LOD is 0.0008% and 0.013%, respectively. Conclusions. An accurate, reproducible, and selective HPLC method for determining related substances in a combined liquid dosage form (ibuprofen and caffeine syrup) was developed and validated, taking into account stress degradation studies. Experimental studies substantiated the optimal chromatographic conditions